LITTLE ROCK, Ark. -- The Arkansas Department of Health along with federal health organizations and other states are investigating reports of infections among 20 patients in Illinois (5), North Carolina (2), and Florida (13) who received injections of a steroid, methylprednisolone acetate (MPA), after Dec. 6, 2012, produced by Main Street FamilyPharmacy, LLC, (MSFP) in Newbern, Tenn. Complications identified thus far appear to be limited to skin abscesses at the site of injection and joint infections. There are no reports of meningitis , stroke or death.
Ten clinics in Arkansas have received MPA from the MSFP. All ten have been contacted and are assembling information to assist in the investigation. Individuals who are experiencing any unexplained health problems following an injection of methylprednisolone acetate from one of these clinics are encouraged to contact the clinic or their regular health care provider.